immunology companies

Companies whose enriched business profile is tagged “immunology”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + market data, shown with its as-of date.

• Lilly (Eli) (LLY) Health Care — Eli Lilly is a global pharmaceutical innovator leading the market in metabolic health, including diabetes and obesity treatments, alongside a diverse portfolio of oncology and immunology therapies. ask →
• AbbVie (ABBV) Health Care — A global biopharmaceutical leader focused on developing innovative, specialized therapies for immunology, oncology, neuroscience, and aesthetic medicine. ask →
• ASTRAZENECA PLC (AZN) Health Care — AstraZeneca is a major global biopharmaceutical company dedicated to delivering life-changing medicines across oncology, rare diseases, and diverse chronic conditions. ask →
• Pfizer (PFE) Health Care — A diversified, global biopharmaceutical giant focused on discovering and commercializing life-changing medicines, vaccines, and advanced therapies across key therapeutic areas. ask →
• APOGEE THERAPEUTICS INC (APGE) Health Care — Apogee Therapeutics is a clinical-stage biotechnology firm developing advanced biologic therapies for inflammatory and immunology diseases, currently pending acquisition by AbbVie. ask →
• KYMERA THERAPEUTICS INC (KYMR) Health Care — Kymera Therapeutics is pioneering oral, targeted protein degradation medicines designed to deliver biologic-like efficacy for underserved patients in immunology and beyond. ask →
• KINIKSA PHARMACEUTICALS INTERNATIO (KNSA) Health Care — Kiniksa is a biopharmaceutical company developing and commercializing therapies for chronic inflammatory and autoimmune diseases, with a pipeline featuring novel treatments for recurrent pericarditis. ask →
• ALUMIS INC (ALMS) Health Care — Alumis is a clinical-stage biopharmaceutical company developing targeted TYK2 inhibitors to transform the treatment of immune-mediated and neurodegenerative diseases. ask →
• NURIX THERAPEUTICS INC (NRIX) Health Care — Clinical-stage biotech pioneering AI-powered targeted protein degradation medicines for cancer and autoimmune diseases, with Phase 2 lead candidate bexobrutideg in CLL and partnerships spanning Roche, Gilead, and Sanofi. ask →
• NEKTAR THERAPEUTICS (NKTR) Health Care — Nektar Therapeutics is a clinical-stage biotechnology company developing first-in-class immunomodulatory therapies aimed at restoring immune system balance to treat chronic autoimmune and inflammatory disorders. ask →
• BIOHAVEN LTD (BHVN) Health Care — Biohaven is a biopharmaceutical firm developing a diverse pipeline of innovative therapies for complex diseases in neuroscience, immunology, obesity, and oncology. ask →
• KYVERNA THERAPEUTICS INC (KYTX) Health Care — Kyverna is a clinical-stage immunology biotech developing novel investigational therapeutics with no approved products and complete dependence on successful clinical trial outcomes. ask →
• EVOMMUNE INC (EVMN) Health Care — Evommune is a clinical-stage biotechnology company developing novel treatments for inflammatory diseases, currently advancing a pipeline of product candidates including EVO756 and EVO301. ask →
• X4 PHARMACEUTICALS INC (XFOR) Health Care — A commercial-stage biopharmaceutical company focused on developing and marketing targeted therapies for rare immune system disorders, headlined by its FDA-approved treatment for WHIM syndrome. ask →
• ELEDON PHARMACEUTICALS INC (ELDN) Health Care — Eledon Pharmaceuticals is a clinical-stage biotech developing immune-modulating therapies for autoimmune diseases and organ transplantation. ask →
• TONIX PHARMACEUTICALS HOLDING CORP (TNXP) Health Care — A fully-integrated biopharmaceutical company commercializing TONMYA (cyclobenzaprine sublingual tablets) for fibromyalgia while advancing a pipeline of CNS, immunology, and infectious disease therapies. ask →

Not quite it? Describe exactly what you want →

Data: SEC EDGAR (filings) + market data (fundamentals, delayed daily-close). Figures shown with their as-of date.

Last updated 2026-08-24.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.